Paul R. Fortin
Chercheur universitaire clinicien
Axe Maladies infectieuses et immunitaires
Maladies auto-immunes
Publications
Voir tout-
article Hu S, Carrier ME, Geoffroy MC, Golberg M, Kwakkenbos L, Bartlett SJ, Fortuné C, Gietzen A, Gottesman K, Guillot G, Hummers LK, Lawrie-Jones A, Malcarne VL, Richard M, Sauvé M, Mouthon L, Benedetti A, Thombs BD and
Differential Item Functioning on the Patient Health Questionnaire-8 by Disease Subtype, Language, Sex, and Age among People with Systemic Sclerosis: A Scleroderma Patient-centere…
Arthritis Care Res (Hoboken) 2026.
-
article Becker YLC, Boilard É and Rollet-Labelle E, Lood C, Julien AS, Abrahamowicz M, Allaeys I, Choi M, Leclerc J, Lévesque T, Urowitz M, Hanly JG, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Wallace D, Isenberg D, Rahman A, Merrill J, Gladman DD, Bruce IN, Petri M, Ginzler E, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcόn GS, van Vollenhoven R, Aranow C, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase A, Buyon J, Fortin PR
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality
Ann Rheum Dis 2025.
-
article Garg S, Blanchet B, Nguyen Y, Hollnagel F, Clarke A, Petri M, Urowitz MB, Hanly JG, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón GS, Van Vollenhoven RF, Aranow C, Le Guern V, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Buyon J, Chezel J, Puszkiel A, Costedoat-Chalumeau N
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring
Arthritis Rheumatol 2025.
Projets
- Canada research chair in Innovate Systemic Autoimmune Rheumatic Disease, du 2019-07-01 au 2026-06-30
- Role of phosphatidylserine-specific phospholipase A1 (PLA1A) in the pathogenesis of rheumatic diseases, du 2023-01-01 au 2026-04-30
- Role of megakaryocytes in Systemic Lupus Erythematosus, du 2023-04-01 au 2028-03-31
- Risk stratification and personalized therapy in lupus pregnancies, du 2022-10-01 au 2027-09-30
- The contribution of platelets and B-cells to neurolupus pathophysiology, du 2025-10-01 au 2030-09-30
- Pilot Implementation of the Purple Butterfly: Transforming Communication and Self-Management in Lupus Care, du 2025-09-23 au 2026-03-31
- Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis, du 2020-04-01 au 2025-03-31
- FcgRI as a potential therapeutic target in inflammatory arthritis, du 2022-01-01 au 2025-12-31
- Mitochondrial mArkers To Characterize Heterogeneity in SLE (MATCH-SLE) (Planning grant), du 2024-12-01 au 2025-02-28
- Mental Health in Individuals with Autoimmune Rheumatic Diseases During the Transition to Parenthood: A Mixed Methods Study to Identify Associated Factors and Support Needs, du 2023-04-01 au 2025-09-30